Documents
Application Sponsors
Marketing Status
Application Products
001 | IMPLANT;INTRAVITREAL | 0.7MG | 1 | OZURDEX | DEXAMETHASONE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2009-06-17 | PRIORITY |
LABELING; Labeling | SUPPL | 2 | AP | 2010-08-31 | UNKNOWN |
EFFICACY; Efficacy | SUPPL | 3 | AP | 2010-09-24 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2012-02-24 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2012-09-07 | STANDARD |
LABELING; Labeling | SUPPL | 8 | AP | 2014-02-07 | STANDARD |
EFFICACY; Efficacy | SUPPL | 9 | AP | 2014-06-28 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2014-09-26 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 11 | AP | 2016-02-05 | PRIORITY |
LABELING; Labeling | SUPPL | 12 | AP | 2018-05-15 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2020-10-21 | STANDARD |
LABELING; Labeling | SUPPL | 16 | AP | 2022-12-19 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 6 |
SUPPL | 2 | Null | 6 |
SUPPL | 3 | Null | 6 |
SUPPL | 5 | Null | 7 |
SUPPL | 7 | Null | 6 |
SUPPL | 8 | Null | 6 |
SUPPL | 9 | Null | 7 |
SUPPL | 10 | Null | 7 |
SUPPL | 11 | Null | 0 |
SUPPL | 12 | Null | 15 |
SUPPL | 13 | Null | 6 |
SUPPL | 16 | Null | 6 |
CDER Filings
ALLERGAN
cder:Array
(
[0] => Array
(
[ApplNo] => 22315
[companyName] => ALLERGAN
[docInserts] => ["",""]
[products] => [{"drugName":"OZURDEX","activeIngredients":"DEXAMETHASONE","strength":"0.7MG","dosageForm":"IMPLANT;INTRAVITREAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"05\/15\/2018","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/022315s012lbl.pdf\"}]","notes":""},{"actionDate":"09\/26\/2014","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022315s010lbl.pdf\"}]","notes":""},{"actionDate":"06\/28\/2014","submission":"SUPPL-9","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022315s009lbl.pdf\"}]","notes":""},{"actionDate":"02\/07\/2014","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/022315s008lbl.pdf\"}]","notes":""},{"actionDate":"09\/07\/2012","submission":"SUPPL-7","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/022315s007lbl.pdf\"}]","notes":""},{"actionDate":"02\/24\/2012","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/022315s005lbl.pdf\"}]","notes":""},{"actionDate":"09\/24\/2010","submission":"SUPPL-3","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2010\\\/022315s003lbl.pdf\"}]","notes":""},{"actionDate":"06\/17\/2009","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022315lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"OZURDEX","submission":"DEXAMETHASONE","actionType":"0.7MG","submissionClassification":"IMPLANT;INTRAVITREAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2018-05-15
)
)